Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase

Blood

Volumn 114, Issue 8, 2009, Pages 1576-1584

  Ren, Mingqiang ^a   Li, Xiurong ^b   Cowell, John K ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 7 RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 198; CARRIER PROTEIN; DNA BINDING PROTEIN; HYBRID PROTEIN; ZFP198 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMATOPOIETIC STEM CELL; HOMOZYGOSITY; MALE; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; STEM CELL; T CELL LYMPHOMA; UPREGULATION; ZINC FINGER MOTIF; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL CULTURE; CELL TRANSFORMATION; DISEASE MODEL; DNA FINGERPRINTING; GENETICS; PATHOLOGY; PHYSIOLOGY; TRANSPLANTATION;

ANIMALS; CARRIER PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA FINGERPRINTING; DNA-BINDING PROTEINS; FEMALE; HEMATOPOIETIC STEM CELLS; LYMPHOMA, T-CELL; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; MYELOPROLIFERATIVE DISORDERS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECOMBINANT FUSION PROTEINS;

EID: 70349580691     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-03-212704     Document Type: Article

References (37)

1. Tefferi A, Gilliland DG. Oncogenes in myeloproliferative disorders. Cell Cycle. 2007;6:550-566.
2. Still IH, Chernova O, Hurd D, Stone RM, Cowell JK. Molecular characterization of the t(8;13)(p11;q12) translocation associated with an atypical myeloproliferative disorder: evidence for three discrete loci involved in myeloid leukemias on 8p11. Blood. 1997;90:3136-3141. (Pubitemid 27444208)
3. Xiao S, Nalabolu SR, Aster JC, et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukemia/lymphoma syndrome. Nat Genet. 1998;18:84-87. (Pubitemid 28027887)
4. Guasch G, Mack GJ, Popovici C, et al. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood. 2000;95:1788-1796. (Pubitemid 30120844)
5. Popovici C, Zhang B, Gregoire MJ, et al. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood. 1999;93:1381-1389. (Pubitemid 29076154)
6. Still IH, Cowell JK. The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13. Blood. 1998;92:1456-1458.
7. Suzan F, Guasch G, Terre C, et al. Long-term complete haematologic and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12). Br J Haematol. 2003;121:312-314. (Pubitemid 36560599)
8. Wong WS, Cheng KC, Lau KM, et al. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases. Leuk Res. 2007;31:235-238.
9. Kuskonmaz B, Kafali C, Akcoren Z, Karabulut HG, Akalin I, Tuncer MA. The 8p11 myeloproliferative syndrome in a 3-year-old child. Leuk Res. 2008;32:198-199. (Pubitemid 350100842)
10. Sahin F, Sercan Z, Ertan Y, et al. Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: a case report. Hematology. 2007;12:489-492. (Pubitemid 350048057)
11. Etienne A, Gelsi-Boyer V, Carbuccia N, et al. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder. Cancer Genet Cytogenet. 2007;173:154-158. (Pubitemid 46281346)
12. Krause DS, Van Etten RA. Right on target: eradicating leukemic stem cells. Trends Mol Med. 2007;13:470-481. (Pubitemid 350086980)
13. Mozziconacci MJ, Carbuccia N, Prebet T, et al. Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature. Leuk Res. 2008;32:1304-1308.
14. Roumiantsev S, Krause DS, Neumann CA, et al. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations. Cancer Cell. 2004;5:287-298. (Pubitemid 38402120)
15. Chen J, Deangelo DJ, Kutok JL, et al. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci U S A. 2004;101:14479-14484.
16. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10:789-799.
17. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683-692.
18. Baumann H, Kunapuli P, Tracy E, Cowell JK. The oncogenic fusion protein-tyrosine kinase ZNF198/fibroblast growth factor receptor-1 has signaling function comparable with interleukin-6 cytokine receptors. J Biol Chem. 2003;278:16198-16208.
19. Schwaller J, Frantsve J, Aster J, et al. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J. 1998;17:5321-5333. (Pubitemid 28427047)
20. Kozak SL, Kabat D. Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production. J Virol. 1990;64:3500-3508. (Pubitemid 20219556)
21. Li S, Ilaria RL Jr, Million RP, Daley GQ, Van Etten RA. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med. 1999;189:1399-1412. (Pubitemid 29227526)
22. Ema H, Morita Y, Yamazaki S, et al. Adult mouse hematopoietic stem cells: purification and single-cell assays. Nat Protoc. 2006;1:2979-2987.
23. Kawamoto H, Ohmura K, Fujimoto S, Lu M, Ikawa T, Katsura Y. Extensive proliferation of T cell lineage-restricted progenitors in the thymus: an essential process for clonal expression of diverse T cell receptor β chains. Eur J Immunol. 2003;33:606-615. (Pubitemid 36367664)
24. Cowell JK, Nowak NJ. High-resolution analysis of genetic events in cancer cells using bacterial artificial chromosome arrays and comparative genome hybridization. Adv Cancer Res. 2003;90:91-125.
25. Cowell JK, Matsui S, Wang YD, et al. Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme. Cancer Genet Cytogenet. 2004;151:36-51. (Pubitemid 38569631)
26. Rossi MR, La Duca J, Matsui S, Nowak NJ, Hawthorn L, Cowell JK. Novel amplicons on the short arm of chromosome 7 identified using high resolution array CGH contain overexpressed genes in addition to EGFR in glioblastoma multiforme. Genes Chromosomes Cancer. 2005;44:392-404. (Pubitemid 41476790)
27. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 2004;5:557-572. (Pubitemid 41180205)
28. Lo KC, Rossi MR, Eberhart CG, Cowell JK. Genome wide copy number abnormalities in pediatric medulloblastomas as assessed by array comparative genome hybridization. Brain Pathol. 2007;17:282-296.
29. Kasyapa CS, Kunapuli P, Hawthorn L, Cowell JK. Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease. Blood. 2006;107:3693-3699.
30. Inhorn RC, Aster JC, Roach SA, et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood. 1995;85:1881-1887.
31. Hawthorn LA, Chapman R, Oscier D, Cowell JK. The consistent 13q14 translocation breakpoint seen in chronic B cell leukemia (BCLL) involves deletion of the D13S25 locus which lies distal to the retinoblastoma predisposition gene. Oncogene. 1993;8:1415-1419. (Pubitemid 23189036)
32. Kuhns MS, Davis MM. The safety on the TCR trigger. Cell. 2008;135:594-596.
33. Anderson G, Moore NC, Owen JJ, Jenkinson EJ. Cellular interactions in thymocyte development. Annu Rev Immunol. 1996;14:73-99.
34. Matei IR, Gladdy RA, Nutter LM, Canty A, Guidos CJ, Danska JS. ATM deficiency disrupts Tcra locus integrity and the maturation of CD4+CD8+ thymocytes. Blood. 2007;109:1887-1896.
35. Vacchio MS, Olaru A, Livak F, Hodes RJ. ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor α locus coding end breaks. Proc Natl Acad Sci U S A. 2007;104:6323-6328. (Pubitemid 47186093)
36. Wiener F, Ohno S, Spira J, Haran-Ghera N, Klein G. Chromosome changes (trisomies #15 and 17) associated with tumor progression in leukemias induced by radiation leukemia virus. J Natl Cancer Inst. 1978;61:227-237. (Pubitemid 8382816)
37. Cowell JK. Consistent chromosome abnormalities associated with mouse bladder epithelial cell lines transformed in vitro. J Natl Cancer Inst. 1980;65:955-961.